Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed Conditions

This study has been completed.
Information provided by:
Sandoz Identifier:
First received: March 5, 2009
Last updated: NA
Last verified: March 2009
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2007
  Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)